Early-life gut microbiome development and its potential long-term impact on health outcomes

Area of Science:

• Microbiology and Immunology
• Developmental Biology
• Public Health

Background:

• The infant gut microbiome (GM) is established early in life and significantly impacts immune, intestinal, and metabolic development.
• Factors like birth mode, feeding, and antibiotic exposure influence GM composition.
• Gut microbiome dysbiosis in early life can disrupt normal development, leading to adverse long-term health outcomes.

Purpose of the Study:

• To review current knowledge on early-life GM development and its long-term health implications.
• To explore how early-life GM dysbiosis contributes to diseases like allergies, metabolic disorders, and inflammatory conditions.
• To examine the role of probiotics, prebiotics, and early-life stress (ELS) in shaping the infant GM and subsequent health.

Main Methods:

• This study is a narrative review synthesizing existing research.
• It analyzes findings on the impact of various early-life factors on GM composition and function.
• The review discusses the link between ELS, GM dysbiosis, and mental health outcomes.

Main Results:

• Early-life GM dysbiosis is associated with increased risk for allergic diseases, metabolic disorders, type 1 diabetes, IBD, and cardiovascular diseases.
• Probiotic and prebiotic supplementation may influence infant GM composition.
• ELS is linked to GM alterations, but a definitive microbiome signature for prenatal or postnatal stress requires further investigation.

Conclusions:

• The early-life microbiota has lasting effects on physiological health, with insufficient microbial exposure potentially triggering inflammatory responses.
• Targeting modifiable factors influencing the GM could improve gut health, particularly in vulnerable children.
• Further research is needed to establish causality and develop effective interventions for ELS-affected infants.